Literature DB >> 9658201

Chimeric melanocortin MC1 and MC3 receptors: identification of domains participating in binding of melanocyte-stimulating hormone peptides.

H B Schiöth1, P Yook, R Muceniece, J E Wikberg, M Szardenings.   

Abstract

The melanocortin receptors MC1 and MC3 are G protein-coupled receptors that have substantial structural similarities and bind melanocyte peptides but with different affinity profiles. We constructed a series of chimeric MC1/MC3 receptors to identify the epitopes that determine their selectivities for natural melanocyte peptides and synthetic analogues. The chimeric constructs were made by a polymerase chain reaction that used identical regions in or just outside transmembranes (TM) 1, 4, and 6 and divided the receptors into four segments. Saturation and competition studies on the expressed chimeric proteins indicate that TM1, TM2, TM3, and TM7 are involved in the subtype-specific binding of melanocyte peptides to these receptors. The results support the hypothesis that TM4 and TM5 may not contribute to the ligand-binding specificity of the MC receptors. This is the first report to describe the subtype-specific hormone-binding domains of the melanocortin receptor family.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9658201     DOI: 10.1124/mol.54.1.154

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  3 in total

1.  Selected melanocortin 1 receptor single-nucleotide polymorphisms differentially alter multiple signaling pathways.

Authors:  J R Doyle; J P Fortin; M Beinborn; A S Kopin
Journal:  J Pharmacol Exp Ther       Date:  2012-04-30       Impact factor: 4.030

2.  Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity.

Authors:  Ningping Feng; Sharla F Young; Greti Aguilera; Elena Puricelli; Diane C Adler-Wailes; Nancy G Sebring; Jack A Yanovski
Journal:  Diabetes       Date:  2005-09       Impact factor: 9.461

Review 3.  ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?

Authors:  Davids Fridmanis; Ance Roga; Janis Klovins
Journal:  Front Endocrinol (Lausanne)       Date:  2017-02-06       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.